B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions.
Based on the new United States Pharmacopeia (USP) standards for heparin products released by the U.S. Food and Drug Administration (FDA) in October 2009, changes to B. Braun's large volume heparin IV solutions include a modification of the reference standard for the drug's unit dose.
The following heparin infusion solutions are now available from B. Braun without restriction:
- P5671, Heparin Sodium (40 U/mL) in 5% Dextrose Injection (500 mL EXCEL® Plastic Container)
- P5771, Heparin Sodium (50 U/mL) in 5% Dextrose Injection (500 mL EXCEL® Plastic Container)
- P5872, Heparin Sodium (100 U/mL) in 5% Dextrose Injection (250 mL EXCEL® Plastic Container)
In addition, the following heparin infusion solutions remain available on allocation:
- P8721, Heparin Sodium (2 U/mL) in 0.9% Sodium Chloride Injection (500 mL EXCEL® Plastic Container)
B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy